FDA Webview

Free FDA Notices

Guidance on Compounding Facilities Insanitary Conditions


Federal Register Notice: FDA is making available a draft guidance for industry entitled Insanitary Conditions at Compounding Facilities. FDA is issuing this draft guidance to assist compounding facilities in identifying insanitary conditions so that they can implement appropriate corrective actions, and to assist state regulatory agencies in understanding some examples of what FDA considers to be insanitary conditions. To download this guidance, click here. To view this notice, click here.